Clinical Trial Update: A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1 [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing different doses of UK-453,061 plus Truvada to Efavirenz plus Truvada in treatment-naive HIV-1 patients; the study completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)
• UK-453,061

Snippet

Sponsor: Pfizer | Conditions: HIV-1 | Phase 2 | Status: COMPLETED | Results posted: 2014-01-24